Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Harrison-Woolrych

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The New Zealand Medical Journal|October 9, 2008
Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring ProgrammeGeraldine R Hill, Mira Harrison-Woolrych
International Clinical Psychopharmacology|February 13, 2007
Alopecia associated with quetiapineRachael M McLean, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|December 4, 2004
Sibutramine may be associated with memory impairmentDavid W J Clark, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 12, 2004
Nose bleeds associated with use of risperidoneMira Harrison-Woolrych, David W J Clark
Contraception|January 11, 2003
Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?Mira Harrison-Woolrych, Janelle Ashton, David Coulter
The New Zealand Medical Journal|September 27, 2003
Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New ZealandMira Harrison-Woolrych, Lifeng Zhou, David Coulter
Contraception|December 25, 2002
Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand womenMira Harrison-Woolrych, Janelle Ashton, David Coulter
Current Drug Safety|August 12, 2008
The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactionsDavid W J Clark, Mira Harrison-Woolrych
Contraception|May 16, 2009
A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescentsHelen Paterson, Janelle Ashton, Mira Harrison-Woolrych
Drug Safety|June 18, 2010
Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort studyMira Harrison-Woolrych, Janelle Ashton, Peter Herbison
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The New Zealand Medical Journal|October 9, 2008
Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring ProgrammeGeraldine R Hill, Mira Harrison-Woolrych
International Clinical Psychopharmacology|February 13, 2007
Alopecia associated with quetiapineRachael M McLean, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|December 4, 2004
Sibutramine may be associated with memory impairmentDavid W J Clark, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 12, 2004
Nose bleeds associated with use of risperidoneMira Harrison-Woolrych, David W J Clark
Contraception|January 11, 2003
Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?Mira Harrison-Woolrych, Janelle Ashton, David Coulter
The New Zealand Medical Journal|September 27, 2003
Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New ZealandMira Harrison-Woolrych, Lifeng Zhou, David Coulter
Contraception|December 25, 2002
Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand womenMira Harrison-Woolrych, Janelle Ashton, David Coulter
Current Drug Safety|August 12, 2008
The role of the New Zealand Intensive Medicines Monitoring Programme in identification of previously unrecognised signals of adverse drug reactionsDavid W J Clark, Mira Harrison-Woolrych
Contraception|May 16, 2009
A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescentsHelen Paterson, Janelle Ashton, Mira Harrison-Woolrych
Drug Safety|June 18, 2010
Fatal and non-fatal cardiovascular events in a general population prescribed sibutramine in New Zealand: a prospective cohort studyMira Harrison-Woolrych, Janelle Ashton, Peter Herbison
Pageof 5